China Justice Observer

中司观察

EnglishArabicChinese (Simplified)DutchFrenchGermanHindiItalianJapaneseKoreanPortugueseRussianSpanishSwedishHebrewIndonesianVietnameseThaiTurkishMalay

China Enhances Sci-Tech Ethics Oversight

Wed, 29 Nov 2023
Categories: China Legal Trends

On 9 Oct. 2023, ten Chinese government departments, including the Ministry of Science and Technology, the Ministry of Education, and the Ministry of Industry and Information Technology, jointly issued the “Measures for Scientific and Technological Ethics Review (for Trial Implementation)” (科技伦理审查办法(试行), hereinafter the “Measures”)

The Measures aim to regulate the ethical review of scientific research, technology development, and other scientific and technological (“sci-tech”) activities, so as to strengthen the prevention and control of sci-tech ethical risks and promote responsible innovation.

According to the Measures, sci-tech activities that shall be subject to sci-tech ethical review include:

  1. sci-tech activities involving human research participants, including human testing, investigation, observation, and other research activities, and sci-tech activities utilizing human biological samples and personal information, among others;
  2. sci-tech activities involving laboratory animals;
  3. sci-tech activities that do not directly involve humans or laboratory animals but may pose ethical risks and challenges to areas such as life and health, ecology and the environment, public order, sustainable development; and
  4. other sci-tech activities that shall be subject to sci-tech ethical review in accordance with laws.

The Measures include a list of sci-tech activities that require ethical review in the Annex, such as:

  1. research on synthesizing new species with significant impact;
  2. related research on the introduction of human stem cells into animal embryos or fetuses and further development into individuals in the animal uterus;
  3. basic research that alters the genetic material or genetic rules of human germ cells, fertilized eggs, and pre-implantation embryo cells;
  4. clinical research of invasive brain-computer interface for the treatment of neurological and psychiatric disorders;
  5. research and development of human-machine integration systems that have strong influences on human subjective behaviors, psychological emotions, and life and health, among others;
  6. research and development of algorithmic models, applications, and systems with the ability to mobilize the public and guide social consciousness; and
  7. research and development of highly autonomous decision-making systems for scenarios involving safety and personal health risks.

 

 

Photo by Stefan Wagener on Unsplash

Contributors: CJO Staff Contributors Team

Save as PDF

You might also like

ABLI-HCCH webinar: Cross-Border Commercial Dispute Resolution – Electronic Service of Documents and Remote Taking of Evidence (July 10, 2025)

The Asian Business Law Institute (ABLI) and the Hague Conference on Private International Law (HCCH) will host their fourth joint webinar on July 10, 2024 (5:00–6:10 PM SGT), focusing on electronic service of documents and remote taking of evidence under the Service and Evidence Conventions, featuring expert speakers, with an early bird discount available until June 10.

SPC Releases Typical Cases on Telecom Fraud Crimes

In February 2025, China's Supreme People's Court (SPC) released eight typical telecom fraud cases, exposing new criminal methods and highlighting intensified judicial efforts after handling 31,000 such cases in 2023.

SPC Targets Cyber Extortion with Typical Cases

In February 2025, China’s Supreme People’s Court (SPC) released six typical cases showcasing its crackdown on emerging cyber extortion crimes, including spreading rumors and sextortion, to encourage victims to seek legal protection.

China Issues New Rules on Foreign-Related IP Disputes

In March 2025, China issued regulations effective May 1, 2025, to enhance dispute resolution, evidence collection, and countermeasures for foreign-related intellectual property disputes, strengthening services and enterprise capabilities.

SPC Issues China’s First Anti-Anti-Suit Injunction (AASI) in IP Case

In December 2024, China’s Supreme People’s Court (SPC) issued its first anti-anti-suit injunction in a patent dispute, Huawei v. Netgear, prohibiting Netgear from obstructing Huawei’s Chinese litigation, marking a significant step in global standard-essential patent governance.

SPC Launches Diversified Dispute Resolution Case Database

In February 2025, China's Supreme People's Court launched a public “Diversified Dispute Resolution Case Database” with over 200 cases, showcasing mediation and arbitration examples across various dispute types to guide alternative dispute resolution.